A MUM suffering severe bloating died after she had a suspected allergic reaction to a CT scan. Yvonne Graham, 66, went into ...

Bladder cancer is not the only cancer affected by the rule. Patients diagnosed with pancreatic, skin and thyroid cancers ...

Kennedy, President Donald Trump's pick to run the U.S. Department of Health and Human Services, Senate confirmation hearings are scheduled Wednesday and Thursday, Jan. 29-30.

As Trump withdraws the US from the World Health Organisation, experts say his controversial new health secretary could have ...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...